Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: monoclonal antibody drugs


Lack of independent sources weaken NBC’s look at pricey eczema drug


Bloomberg’s conflicted sources ‘love’ new cholesterol drugs — readers need to know about financial relationships with pharma


Potential conflicts of interest abound in HealthDay’s look at Lemtrada for early stages of MS


Except for presidential anecdote, NBC story on new melanoma drug was well-balanced